Gene transfer to the gastrointestinal tract after peroral administration of recombinant adeno-associated virus type 2 vectors

Journal of Pediatric Gastroenterology and Nutrition

Volumn 43, Issue 2, 2006, Pages 168-179

  Shao, Guohong ^a,b   Greathouse, Kristin ^a   Huang, Qin ^a   Wang, Chiou Miin ^a   Sferra, Thomas J ^a,b  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Adeno associated virus; Aprotinin; Gastrointestinal tract; Gene therapy; Gene transfer

Indexed keywords

APROTININ; BETA GALACTOSIDASE; BICARBONATE; CHYMOTRYPSIN; ENHANCED GREEN FLUORESCENT PROTEIN; HYDROCHLORIC ACID; INTESTINE ENZYME; PARVOVIRUS VECTOR; PEPSIN A; PROTEINASE; TRYPSIN;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG STABILITY; EVALUATION; EXPERIMENTATION; EXPRESSION VECTOR; GASTROINTESTINAL TRACT; GENE EXPRESSION; GENE TRANSFER; GENETIC MANIPULATION; GENETIC TRANSDUCTION; HISTOCHEMISTRY; IN VIVO STUDY; INTESTINE; INTESTINE FLUID; MOUSE; MOUSE STRAIN; NONHUMAN; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEINASE INHIBITION; SMALL INTESTINE ABSORPTION; STOMACH; STOMACH ACID; STOMACH JUICE; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

ANIMALS; APROTININ; BETA-GALACTOSIDASE; BIOTECHNOLOGY; DEPENDOVIRUS; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTRIC ACID; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MICE; MICE, INBRED STRAINS; POLYMERASE CHAIN REACTION; SODIUM BICARBONATE; SPECIFIC PATHOGEN-FREE ORGANISMS;

ADENO-ASSOCIATED VIRUS - 2;

EID: 33746800249     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000228118.59853.ba     Document Type: Article

References (36)

1. Wirtz S, Neurath MF. Gene transfer approaches for the treatment of inflammatory bowel disease. Gene Ther 2003;10:854-60.
2. Prieto J, Herraiz M, Sangro B, et al. The promise of gene therapy in gastrointestinal and liver diseases. Gut 2003;52(2(suppl)):ii49-ii54.
3. Fujita Y, Cheung AT, Kieffer TJ. Harnessing the gut to treat diabetes. Pediatr Diabetes 2004;5(2(suppl)):57-69.
4. Crotty S, Andino R. Poliovirus vaccine strains as mucosal vaccine vectors and their potential use to develop an AIDS vaccine. Adv Drug Deliv Rev 2004;56:835-52.
5. Morral N. Gene therapy for type 1 diabetes. Minerva Med 2004;95:93-104.
6. van Montfrans C, te Velde AA, van Deventer SJ, et al. Gene therapy in the treatment of intestinal inflammation. Int J Colorectal Dis 2004;19:79-86.
7. During MJ, Xu R, Young D, et al. Peroral gene therapy of lactose intolerance using an adeno-associated virus vector. Nat Med 1998;10:1131-5.
8. During MJ, Symes CW, Lawlor PA, et al. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science 2000;287:1453-60.
9. Dumon DR, Ishii H, Fong LYY, et al. FHIT gene therapy prevents tumor development in Fhit-deficient mice. Proc Natl Acad Sci U S A 2001;98:3346-51.
10. Xin K-Q, Ooki T, Mizukami H, et al. Oral administration of recombinant adeno-associated virus elicits human immunodeficiency virus-specific immune responses. Hum Gene Ther 2002;13:1571-81.
11. Hara H, Monsonego A, Yuasa K, et al. Development of a safe oral Aâ vaccine using recombinant adeno-associated virus vector for Alzheimer's disease. J Alzheimers Dis 2004;6:483-8.
12. Erles K, Sebokova P, Schlehofer JR. Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV). J Med Virol 1999;59:406-11.
13. Srivastava A, Lusby EW, Berns KI. Nucleotide sequence and organization of the adeno-associated virus 2 genome. J Virol 1983;45:555-64.
14. Samulski RJ, Chang LS, Shenk T. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol 1989;63:3822-8.
15. Chiorini JA, Yang L, Liu Y, et al. Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles. J Virol 1997;71(9):6823-33.
16. Rutledge EA, Halbert CL, Russell DW. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J Virol 1998;72:309-19.
17. Chiorini JA, Kim F, Yang L, et al. Cloning and characterization of adeno-associated virus type 5. J Virol 1999;73(2):1309-19.
18. Rabinowitz JE, Rolling F, Li C, et al. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol 2002;76:791-801.
19. Gao G-P, Alvira MR, Wang L, et al. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 2002;99:11854-9.
20. Carter BJ. Adeno-associated virus vectors in clinical trials. Hum Gene Ther 2005;16:541-50.
21. Clark KR, Sferra TJ, Johnson PR. Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle. Hum Gene Ther 1997;8:659-69.
22. Uetsuki T, Naito A, Nagata S, et al. Isolation and characterization of the human chromosomal gene for polypeptide chain elongation factor-1 alpha. J Biol Chem 1989;264:5791-8.
23. Clark KR, Voulgaropoulou F, Fraley DM, et al. Cell lines for the production of recombinant adeno-associated virus. Hum Gene Ther 1995;6:1329-41.
24. Clark KR, Liu X, McGrath JP, et al. Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Hum Gene Ther 1999;10:1031-9.
25. Clark KR, Voulgaropoulou F, Johnson PR. A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors. Gene Ther 1996;3:1124-32.
26. Sferra TJ, Qu G, McNeely D, et al. Recombinant adeno-associated virus-mediated correction of lysosomal storage within the central nervous system of the adult mucopolysaccharidosis type VII mouse. Hum Gene Ther 2000;11(4):507-19.
27. Sferra TJ, McNeely D, Johnson PR. Gene transfer to the intestinal tract: a new approach using selective injection of the superior mesenteric artery. Hum Gene Ther 1997;8:681-7.
28. MacGregor GR, Nolan GP, Fireing S, et al. Use of E. coli lacZ (b-galactosidase) as a reporter gene. In: Murray EJ, ed. Methods in Molecular Biology. Clifton, NJ: Humana Press Inc, 1991:217-35.
29. Ding W, Yan Z, Zak R, et al. Second-strand genome conversion of adeno-associated virus type 2 (AAV-2) and AAV-5 is not rate limiting following apical infection of polarized human airway epithelia. J Virol 2003;77(13):7361-6.
30. Moon HW, Fung PY, Isaacson RE, et al. Effects of age, ambient temperature, and heat-stable Escherichia coli enterotoxin on intestinal transit in infant mice. Infect Immun 1979;25:127-32.
31. Beekes M, McBride PA. Early accumulation of pathological PrP in the enteric nervous system and gut-associated lymphoid tissue of hamsters orally infected with scrapie. Neurosci Lett 2000;278:181-4.
32. Johnson FB, Bodily AS. Effect of environmental pH on adenovirus- associated virus. Proc Soc Exp Biol Med 1975;150:585-90.
33. Crawford SE, Mukherjee SK, Estes MK, et al. Trypsin cleavage stabilizes the rotavirus VP4 spike. J Virol 2001;75:6052-61.
34. Turnbull AE, Skulimowski A, Smythe JA, et al. Adeno-associated virus vectors show variable dependence on divalent cations for thermostability: implications for purification and handling. Hum Gene Ther 2000;11:629-35.
35. Ascenzi P, Bocedi A, Bolognesi M, et al. The bovine basic pancreatic trypsin inhibitor (Kunitz inhibitor): a milestone protein. Curr Protein Pept Sci 2003;4(3):231-51.
36. Beierlein W, Scheule AM, Dietrich W, et al. Forty years of clinical aprotinin use: a review of 124 hypersensitivity reactions. Ann Thorac Surg 2005;79:741-8.